首页 | 本学科首页   官方微博 | 高级检索  
     

肝细胞癌患者TACE介入治疗前后血清sICAM-1检测的临床意义
引用本文:孙业全,李绪斌,许福亮,李公宝,纪恩美. 肝细胞癌患者TACE介入治疗前后血清sICAM-1检测的临床意义[J]. 潍坊医学院学报, 2005, 27(6): 428-430
作者姓名:孙业全  李绪斌  许福亮  李公宝  纪恩美
作者单位:潍坊医学院附属医院,山东,潍坊,261031
摘    要:目的探讨肝细胞癌患者血清可溶性细胞间粘附分子-1(sICAM-1)在肝动脉栓塞化疗(TACE)介入治疗前、后水平的变化.方法肝细胞癌患者35例,健康人30例,采用酶联免疫吸附(ELISA)法,测定健康人及介入治疗前后的肝细胞癌患者血清sICAM-1水平.结果介入治疗前、后血清sICAM-1水平均显著高于正常人(P<0.05),肝细胞癌患者介入治疗前sICAM-1明显高于介入治疗后(P<0.05).结论 TACE可降低肝细胞癌患者血清sICAM-1的水平,提示检测血清sICAM-1有可能作为诊断肝细胞癌及评价其TACE疗效的一个新指标.

关 键 词:肝肿瘤  血清可溶性细胞间粘附分子  酶联免疫吸附法
文章编号:1004-3101(2005)06-0428-03
收稿时间:2005-06-04
修稿时间:2005-06-04

The Clinical Significnace of Serum sICAM-1 Changes in Hepatocellular Carcinoma Patients Before and After Transcatheter Arterial Chemoembolization
SUN Ye-quan,LI Xu-bin,XU Fu-liang,LI Gong-bao,JI En-mei. The Clinical Significnace of Serum sICAM-1 Changes in Hepatocellular Carcinoma Patients Before and After Transcatheter Arterial Chemoembolization[J]. Journal of Weifang Medical College, 2005, 27(6): 428-430
Authors:SUN Ye-quan  LI Xu-bin  XU Fu-liang  LI Gong-bao  JI En-mei
Affiliation:The Affiliated Hospital of Weifang Medical College,Weifang 261031,China
Abstract:Objective To evaluate clinical significance of serum soluble intercellular adhesion molecule-1(sICAM-1) changes in hepatocellular carcinoma patients(HCC) receiving transcatheter arterial chemoembolization(TACE).Methods The serum levels of sICAM-1 in 35 cases of HCC before and after TACE and 30 normal controls were measured by enzyme-linked immunoadsorbent assay(ELISA)and compared.Results The sera levels of sICAM-1 in HCC group were higher than those in control group(P<0.05) and dropped down markedly after TACE(P<0.05).Conclusion The serum level of sICAM-1 can be reduced by TACE and may be used as a new marker of diagnosing HCC and evaluating effect of TACE in HCC patients.
Keywords:Liver neoplasm   Soluble intercellular adhesion molecule-1  Enzyme-linked immunoadsorbent assay
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号